Larry Rubinstein
- Oncology top 0.01%
- Colorectal Cancer Treatments and Studies 24
- PARP inhibition in cancer therapy 18
- Pulmonary and Respiratory Medicine top 0.01%
- Lung Cancer Treatments and Mutations 28
- Hepatology top 0.1%
- Cancer Research top 0.05%
- Cancer Genomics and Diagnostics 33
- Radiology, Nuclear Medicine and Imaging top 0.05%
-
- Statistical Methods in Clinical Trials 41
-
- Health Systems, Economic Evaluations, Quality of Life 20
-
- Cancer therapeutics and mechanisms 14
- DNA Repair Mechanisms 13
- Co-authors
- Susan G. ArbuckRichard KaplanMichaele C. ChristianDaniel J. SargentJanet DanceyLori E. DoddLawrence H. SchwartzMargaret Mooney
- Journals
- Journal of Clinical Oncology (50 papers)Clinical Cancer Research (15 papers)JNCI Journal of the National Cancer Institute (10 papers)
- Partner nations
- United StatesMalaysiaCanada
In The Last Decade
Larry Rubinstein
185 papers receiving 46.7k citations
Hit Papers
Peers
Comparison fields: 5 of 191
- Oncology 22.4k
- Pulmonary and Respiratory Medicine 20.2k
- Hepatology 4.2k
- Cancer Research 7.3k
- Radiology, Nuclear Medicine and Imaging 7.4k
Countries citing papers authored by Larry Rubinstein
This map shows the geographic impact of Larry Rubinstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larry Rubinstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larry Rubinstein more than expected).
Fields of papers citing papers by Larry Rubinstein
This network shows the impact of papers produced by Larry Rubinstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larry Rubinstein. The network helps show where Larry Rubinstein may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Larry Rubinstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 1 | |
| 8 | 2023 | 4 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 1 | |
| 11 | 2020 | 42 | |
| 12 | 2017 | 214 | |
| 13 | 2016 | 6 | |
| 14 | 2015 | 41 | |
| 15 | 2012 | 155 | |
| 16 | 2010 | 56 | |
| 17 | 2010 | 79 | |
| 18 | 2010 | 75 | |
| 19 | Abstract #5456: Correlation between inhibition of the activity of poly(ADP-ribose) polymerase (PARP) in human peripheral blood mononuclear cells (PBMCs) and tumor biopsies following treatment with ABT-888, an inhibitor of PARP | 2009 | 6 |
| 20 | 1993 | 80 |
About Larry Rubinstein
Larry Rubinstein is a scholar working on Statistics and Probability, Oncology and Cancer Research, having authored 196 papers that have together received 47.6k indexed citations. Recurring topics across this work include Statistical Methods in Clinical Trials (41 papers), Cancer Genomics and Diagnostics (33 papers), Lung Cancer Treatments and Mutations (28 papers), Colorectal Cancer Treatments and Studies (24 papers), Health Systems, Economic Evaluations, Quality of Life (20 papers), PARP inhibition in cancer therapy (18 papers), Cancer therapeutics and mechanisms (14 papers) and DNA Repair Mechanisms (13 papers). The work is most often cited by research in Oncology (22.4k citations), Pulmonary and Respiratory Medicine (20.2k citations) and Hepatology (4.2k citations). Larry Rubinstein has collaborated with scholars based in United States, Malaysia and Canada. Frequent co-authors include Susan G. Arbuck, Richard Kaplan, Michaele C. Christian, Daniel J. Sargent, Janet Dancey, Lori E. Dodd, Lawrence H. Schwartz, Margaret Mooney, Lalitha Shankar and Jan Bogaerts. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, JNCI Journal of the National Cancer Institute, Cancer Research and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.